Pfizer Inc said on Wednesday it planned to invest $600 million in its venture capital fund, a quarter of which would be earmarked for promising research on neuroscience.The new funding will bring total assets managed by Pfizer Ventures to over $1 billion, the company said in a statement.The announcement comes six months after the U.S.